Skip to main content

Full Year 2024 – Coming soon!

We will announce our Full Year 2024 results on February 26, 2025. The conference call will take place at 1:30 pm (CET). Please find the dial-in details below.

Our quiet period will start from February 5 to February 25. We will be back on February 26 with all relevant documents to present our financial results, business updates and more.

 

Selected Key Figures Q3/2024

GROUP REVENUE

5305 m

+ 9% 1

Q3/23: €4,967 m

GROUP EBIT 2

552 m

+9% 3

Q3/23: €509 m

NET INCOME 2, 4, 5

312 m

+7% 3

Q3/23: €292 m

EPS 2, 4, 5

0.55

+7% 3

Q3/23: €0.51

1 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation

2 Before special items

3 Growth rate at constant currency (cc) and adjusted for Argentina hyperinflation

4 Net income attributable to shareholders of Fresenius SE & Co. KGaA

5 Excluding Fresenius Medical Care

Revenue by business segment

€ in millions Q3/24 Q3/23 Growth at actual ratesGrowth at constant ratesOrganic growth1Acquisitions/Divestitures% of total revenue

Fresenius Kabi

2,1142,0215%10%11%-1%40%

Fresenius Helios

3,0822,8638%8%8%0%58%

Total

5,3034,9677%9%9%0%100%2

  • 1 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation

    2 Remaining 2% Corporate/Other revenue

    Before special items

Archive